People

Jacob Van Naarden

Jacob Van Naarden leads Lilly Oncology and corporate business development as executive vice president. He joined Lilly through its 2019 acquisition of Loxo Oncology, where he was COO. His earlier work includes biotechnology investing, operations and advisory roles, including HealthCor.

Roles

Eli Lilly and Company

Executive Vice President; President, Lilly Oncology and Head of Corporate Business Development

Current